668 related articles for article (PubMed ID: 31846104)
1. Structural and biochemical analysis of the metallo-β-lactamase L1 from emerging pathogen Stenotrophomonas maltophilia revealed the subtle but distinct di-metal scaffold for catalytic activity.
Kim Y; Maltseva N; Wilamowski M; Tesar C; Endres M; Joachimiak A
Protein Sci; 2020 Mar; 29(3):723-743. PubMed ID: 31846104
[TBL] [Abstract][Full Text] [Related]
2. Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products.
Hinchliffe P; Calvopiña K; Rabe P; Mojica MF; Schofield CJ; Dmitrienko GI; Bonomo RA; Vila AJ; Spencer J
J Biol Chem; 2023 May; 299(5):104606. PubMed ID: 36924941
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic recognition by binuclear metallo-beta-lactamases revealed by X-ray crystallography.
Spencer J; Read J; Sessions RB; Howell S; Blackburn GM; Gamblin SJ
J Am Chem Soc; 2005 Oct; 127(41):14439-44. PubMed ID: 16218639
[TBL] [Abstract][Full Text] [Related]
4. Site-selective binding of Zn(II) to metallo-beta-lactamase L1 from Stenotrophomonas maltophilia.
Costello A; Periyannan G; Yang KW; Crowder MW; Tierney DL
J Biol Inorg Chem; 2006 Apr; 11(3):351-8. PubMed ID: 16489411
[TBL] [Abstract][Full Text] [Related]
5. Probing substrate binding to metallo-beta-lactamase L1 from Stenotrophomonas maltophilia by using site-directed mutagenesis.
Carenbauer AL; Garrity JD; Periyannan G; Yates RB; Crowder MW
BMC Biochem; 2002; 3():4. PubMed ID: 11876827
[TBL] [Abstract][Full Text] [Related]
6. Faropenem reacts with serine and metallo-β-lactamases to give multiple products.
Lucic A; Hinchliffe P; Malla TR; Tooke CL; Brem J; Calvopiña K; Lohans CT; Rabe P; McDonough MA; Armistead T; Orville AM; Spencer J; Schofield CJ
Eur J Med Chem; 2021 Apr; 215():113257. PubMed ID: 33618159
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into the design of inhibitors for the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia.
Nauton L; Kahn R; Garau G; Hernandez JF; Dideberg O
J Mol Biol; 2008 Jan; 375(1):257-69. PubMed ID: 17999929
[TBL] [Abstract][Full Text] [Related]
8. Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States.
Mojica MF; Rutter JD; Taracila M; Abriata LA; Fouts DE; Papp-Wallace KM; Walsh TJ; LiPuma JJ; Vila AJ; Bonomo RA
mBio; 2019 Jul; 10(4):. PubMed ID: 31266860
[No Abstract] [Full Text] [Related]
9. Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes.
Hinchliffe P; González MM; Mojica MF; González JM; Castillo V; Saiz C; Kosmopoulou M; Tooke CL; Llarrull LI; Mahler G; Bonomo RA; Vila AJ; Spencer J
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3745-54. PubMed ID: 27303030
[TBL] [Abstract][Full Text] [Related]
10. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing
Somboro AM; Amoako DG; Osei Sekyere J; Kumalo HM; Khan R; Bester LA; Essack SY
Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478231
[TBL] [Abstract][Full Text] [Related]
11. Clonal diversity and metallo-beta-lactamase production in clinical isolates of Stenotrophomonas maltophilia.
Mercuri PS; Ishii Y; Ma L; Rossolini GM; Luzzaro F; Amicosante G; Franceschini N; Frere JM; Galleni M
Microb Drug Resist; 2002; 8(3):193-200. PubMed ID: 12363008
[TBL] [Abstract][Full Text] [Related]
12. Diaryl-substituted azolylthioacetamides: Inhibitor discovery of New Delhi metallo-β-lactamase-1 (NDM-1).
Zhang YL; Yang KW; Zhou YJ; LaCuran AE; Oelschlaeger P; Crowder MW
ChemMedChem; 2014 Nov; 9(11):2445-8. PubMed ID: 25048031
[TBL] [Abstract][Full Text] [Related]
13. Structure and mechanism of copper- and nickel-substituted analogues of metallo-beta-lactamase L1.
Hu Z; Spadafora LJ; Hajdin CE; Bennett B; Crowder MW
Biochemistry; 2009 Apr; 48(13):2981-9. PubMed ID: 19228020
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor.
Concha NO; Janson CA; Rowling P; Pearson S; Cheever CA; Clarke BP; Lewis C; Galleni M; Frère JM; Payne DJ; Bateson JH; Abdel-Meguid SS
Biochemistry; 2000 Apr; 39(15):4288-98. PubMed ID: 10757977
[TBL] [Abstract][Full Text] [Related]
15. Metal binding Asp-120 in metallo-beta-lactamase L1 from Stenotrophomonas maltophilia plays a crucial role in catalysis.
Garrity JD; Carenbauer AL; Herron LR; Crowder MW
J Biol Chem; 2004 Jan; 279(2):920-7. PubMed ID: 14573595
[TBL] [Abstract][Full Text] [Related]
16. The flavonoid galangin inhibits the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia.
Denny BJ; Lambert PA; West PW
FEMS Microbiol Lett; 2002 Feb; 208(1):21-4. PubMed ID: 11934488
[TBL] [Abstract][Full Text] [Related]
17. 1,2,4-Triazole-3-thione Compounds as Inhibitors of Dizinc Metallo-β-lactamases.
Sevaille L; Gavara L; Bebrone C; De Luca F; Nauton L; Achard M; Mercuri P; Tanfoni S; Borgianni L; Guyon C; Lonjon P; Turan-Zitouni G; Dzieciolowski J; Becker K; Bénard L; Condon C; Maillard L; Martinez J; Frère JM; Dideberg O; Galleni M; Docquier JD; Hernandez JF
ChemMedChem; 2017 Jun; 12(12):972-985. PubMed ID: 28505394
[TBL] [Abstract][Full Text] [Related]
18. Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.
Palacios AR; Rossi MA; Mahler GS; Vila AJ
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32503337
[TBL] [Abstract][Full Text] [Related]
19. In vivo folding of recombinant metallo-beta-lactamase L1 requires the presence of Zn(II).
Periyannan G; Shaw PJ; Sigdel T; Crowder MW
Protein Sci; 2004 Aug; 13(8):2236-43. PubMed ID: 15238636
[TBL] [Abstract][Full Text] [Related]
20. Time-resolved β-lactam cleavage by L1 metallo-β-lactamase.
Wilamowski M; Sherrell DA; Kim Y; Lavens A; Henning RW; Lazarski K; Shigemoto A; Endres M; Maltseva N; Babnigg G; Burdette SC; Srajer V; Joachimiak A
Nat Commun; 2022 Nov; 13(1):7379. PubMed ID: 36450742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
